Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ellard

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Anaesthesia|December 6, 2012
Anaesthesia for vascular emergenciesL Ellard, G Djaiani
Anaesthesia and Intensive Care|October 25, 2014
Veno-venous extracorporeal membrane oxygenation and apnoeic oxygenation for tracheo-oesophageal fistula repair in a previously pneumonectomised patientN F Collins, L Ellard, E Licari, et al.
Gynecologic Oncology|July 22, 2010
A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)H Hirte, A Oza, K Swenerton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2013
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamideK L Noonan, S North, R L Bitting, et al.
Current Oncology (Toronto, Ont.)|August 10, 2012
Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumabM D Seal, C H Speers, S O'Reilly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancerJ Michels, S L Ellard, L Le, et al.
Investigational New Drugs|July 26, 2011
A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancerEmma K Beardsley, Sebastien J Hotte, Scott North, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozoleHeather L McArthur, Karen A Gelmon, Ivo A Olivotto, et al.
Investigational New Drugs|December 19, 2017
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancerEvan Y Yu, Susan L Ellard, Sebastien J Hotte, et al.
Psycho-Oncology|February 7, 2018
Acceptability and satisfaction of project MOVE: A pragmatic feasibility trial aimed at increasing physical activity in female breast cancer survivorsTanya Pullen, Paul Sharp, Joan L Bottorff, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Anaesthesia|December 6, 2012
Anaesthesia for vascular emergenciesL Ellard, G Djaiani
Anaesthesia and Intensive Care|October 25, 2014
Veno-venous extracorporeal membrane oxygenation and apnoeic oxygenation for tracheo-oesophageal fistula repair in a previously pneumonectomised patientN F Collins, L Ellard, E Licari, et al.
Gynecologic Oncology|July 22, 2010
A phase II study of erlotinib (OSI-774) given in combination with carboplatin in patients with recurrent epithelial ovarian cancer (NCIC CTG IND.149)H Hirte, A Oza, K Swenerton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2013
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamideK L Noonan, S North, R L Bitting, et al.
Current Oncology (Toronto, Ont.)|August 10, 2012
Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumabM D Seal, C H Speers, S O'Reilly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2009
A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancerJ Michels, S L Ellard, L Le, et al.
Investigational New Drugs|July 26, 2011
A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancerEmma K Beardsley, Sebastien J Hotte, Scott North, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2009
Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozoleHeather L McArthur, Karen A Gelmon, Ivo A Olivotto, et al.
Investigational New Drugs|December 19, 2017
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancerEvan Y Yu, Susan L Ellard, Sebastien J Hotte, et al.
Psycho-Oncology|February 7, 2018
Acceptability and satisfaction of project MOVE: A pragmatic feasibility trial aimed at increasing physical activity in female breast cancer survivorsTanya Pullen, Paul Sharp, Joan L Bottorff, et al.
Pageof 4